PRESS RELEASE published on 01/18/2024 at 13:00, 2 years 2 months ago Envision Pharma Group Welcomes Industry Veteran and HR Expert Carolyn Bartholdson as Chief People Officer Envision Pharma Group appoints Carolyn Bartholdson as its new Chief People Officer and member of the Executive Leadership Team. With her extensive experience in the life sciences industry, Carolyn is set to play a crucial role in securing and retaining top talent to support Envision's growth. Her strategic vision aligns seamlessly with the company's priorities, and her exceptional leadership experience will be integral to advancing Envision's strategic goals. Envision Pharma Group Talent Acquisition Life Sciences Industry Carolyn Bartholdson Chief People Officer
PRESS RELEASE published on 01/16/2024 at 13:00, 2 years 3 months ago Envision Pharma Group Appoints Life Sciences Industry Veteran Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) to lead the organization's IMC division of experts in medical strategy, medical communications, publications planning and delivery, and patient engagement, delivering smarter, faster outcomes for life sciences clients. With a wealth of experience in the global life sciences industry, Alice brings strategic expertise, knowledge, and insight to drive the company's vision forward and meet client needs. She joins from IPG Health, where she served as EVP, Managing Director, Client Solutions, APAC, and played a pivotal role in business growth and operational excellence. Her commitment to best practices and standards in medical communications is evident in her various leadership roles. Envision Pharma Group, founded in 2001, is a leading global technology-enabled strategic solutions partner for the life sciences industry, working with over 200 pharma and biotech companies. Learn more at www.envisionpharmagroup.com. Envision Pharma Group Alice Choi Medical Communications Life Sciences Clients Global Technology-enabled Strategic Solutions
PRESS RELEASE published on 11/15/2023 at 13:00, 2 years 5 months ago Envision Pharma Group Announces New AI Innovation Board and Appoints Chairwoman
PRESS RELEASE published on 06/15/2023 at 13:00, 2 years 10 months ago OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
PRESS RELEASE published on 05/09/2023 at 13:00, 2 years 11 months ago Envision Pharma Group Announces Appointment of Dr. Deepti Sodhi Jaggi to Board of Directors
PRESS RELEASE published on 05/04/2023 at 13:00, 2 years 11 months ago Envision Pharma Group Appoints Healthcare Industry Expert and Experienced Leader Dr. Jennifer Costello, PharmD, BCPS, CMPP, as Chief Medical Officer
PRESS RELEASE published on 05/03/2023 at 15:05, 2 years 11 months ago Envision Pharma Group Appoints Mike Glover to Senior Vice President, Payer and HTA Solutions to Drive Acceleration and Expansion in Value & Access and Data Analytics
PRESS RELEASE published on 05/01/2023 at 13:00, 2 years 11 months ago Envision Pharma Group Appoints Industry Leader Tino Quintero as General Manager/VP of Market Access & Customer Insights
PRESS RELEASE published on 03/30/2023 at 13:00, 3 years ago Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
PRESS RELEASE published on 03/29/2023 at 17:45, 3 years ago Envision Pharma Group Appoints Life Science Industry Expert James Streeter as New President of Technology, CTO
Published on 04/17/2026 at 02:00, 8 minutes ago UraniumX Announces Closing Of Final Tranche Of Non-Brokered Private Placement
Published on 04/16/2026 at 23:32, 2 hours 36 minutes ago Zomedica Announces “Fourth Friday at Four” Webinar on April 24th: A Behind-the-Scenes Look at Manufacturing Excellence and Operational Scale
Published on 04/16/2026 at 21:30, 4 hours 38 minutes ago Organto Foods Expands Financing Facilities with Rabobank
Published on 04/16/2026 at 15:20, 10 hours 48 minutes ago Datavault AI Goes Live with First Edge GPU Sites in New York and Philadelphia; $1.44B-$1.92B Quantum-Ready Fleet to Reach 100+ U.S. Cities by End of 2026
Published on 04/16/2026 at 23:40, 2 hours 28 minutes ago Coventry Ranks #1 in 2025 Life Settlement League Table Report
Published on 04/16/2026 at 21:37, 4 hours 31 minutes ago Approval of the Offer Document concerning the voluntary tender offer for shares of NEXT RE SIIQ S.p.A.
Published on 04/16/2026 at 21:00, 5 hours 8 minutes ago Vizrt AI Keyer kills the green screen and creates virtual scenes in any environment
Published on 04/16/2026 at 20:35, 5 hours 33 minutes ago EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 19:17, 6 hours 50 minutes ago EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 18:02, 8 hours 6 minutes ago Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
Published on 04/16/2026 at 17:54, 8 hours 14 minutes ago Aéroports de Paris S.A - March 2026 traffic figures